Logo image of AGYS

AGILYSYS INC (AGYS) Stock Fundamental Analysis

USA - NASDAQ:AGYS - US00847J1051 - Common Stock

107.39 USD
+0.1 (+0.09%)
Last: 9/18/2025, 8:00:00 PM
107.39 USD
0 (0%)
After Hours: 9/18/2025, 8:00:00 PM
Fundamental Rating

5

Overall AGYS gets a fundamental rating of 5 out of 10. We evaluated AGYS against 280 industry peers in the Software industry. While AGYS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AGYS is valued quite expensive, but it does show an excellent growth. This makes AGYS very considerable for growth investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

AGYS had positive earnings in the past year.
In the past year AGYS had a positive cash flow from operations.
Of the past 5 years AGYS 4 years were profitable.
Each year in the past 5 years AGYS had a positive operating cash flow.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

The Return On Assets of AGYS (3.29%) is better than 69.29% of its industry peers.
The Return On Equity of AGYS (4.95%) is better than 68.93% of its industry peers.
AGYS's Return On Invested Capital of 7.28% is fine compared to the rest of the industry. AGYS outperforms 77.14% of its industry peers.
AGYS had an Average Return On Invested Capital over the past 3 years of 7.16%. This is below the industry average of 11.76%.
The last Return On Invested Capital (7.28%) for AGYS is above the 3 year average (7.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROIC 7.28%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

The Profit Margin of AGYS (4.85%) is better than 67.14% of its industry peers.
AGYS's Profit Margin has improved in the last couple of years.
AGYS has a better Operating Margin (9.14%) than 73.93% of its industry peers.
In the last couple of years the Operating Margin of AGYS has grown nicely.
AGYS has a Gross Margin (62.13%) which is in line with its industry peers.
AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AGYS is destroying value.
Compared to 1 year ago, AGYS has more shares outstanding
The number of shares outstanding for AGYS has been increased compared to 5 years ago.
AGYS has a worse debt/assets ratio than last year.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 14.11 indicates that AGYS is not in any danger for bankruptcy at the moment.
AGYS's Altman-Z score of 14.11 is amongst the best of the industry. AGYS outperforms 90.71% of its industry peers.
The Debt to FCF ratio of AGYS is 0.25, which is an excellent value as it means it would take AGYS, only 0.25 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.25, AGYS belongs to the top of the industry, outperforming 80.36% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that AGYS is not too dependend on debt financing.
AGYS has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: AGYS outperforms 58.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 14.11
ROIC/WACC0.66
WACC11.05%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

AGYS has a Current Ratio of 1.11. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
AGYS has a Current ratio of 1.11. This is in the lower half of the industry: AGYS underperforms 67.14% of its industry peers.
AGYS has a Quick Ratio of 1.04. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AGYS (1.04) is worse than 69.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.04
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

8

3. Growth

3.1 Past

AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.33%, which is quite impressive.
AGYS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.96% yearly.
AGYS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.92%.
Measured over the past years, AGYS shows a quite strong growth in Revenue. The Revenue has been growing by 11.38% on average per year.
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%

3.2 Future

AGYS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.65% yearly.
Based on estimates for the next years, AGYS will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 67.54, AGYS can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as AGYS.
The average S&P500 Price/Earnings ratio is at 27.41. AGYS is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 50.60, the valuation of AGYS can be described as expensive.
AGYS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, AGYS is valued quite expensively.
Industry RankSector Rank
PE 67.54
Fwd PE 50.6
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AGYS's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as AGYS.
Industry RankSector Rank
P/FCF 63.88
EV/EBITDA 82.73
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AGYS does not grow enough to justify the current Price/Earnings ratio.
AGYS has a very decent profitability rating, which may justify a higher PE ratio.
AGYS's earnings are expected to grow with 19.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.79
PEG (5Y)1.41
EPS Next 2Y16.64%
EPS Next 3Y19.65%

0

5. Dividend

5.1 Amount

AGYS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AGILYSYS INC

NASDAQ:AGYS (9/18/2025, 8:00:00 PM)

After market: 107.39 0 (0%)

107.39

+0.1 (+0.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners102.65%
Inst Owner Change-1.82%
Ins Owners4.4%
Ins Owner Change0.1%
Market Cap3.01B
Analysts83.08
Price Target132.65 (23.52%)
Short Float %6.12%
Short Ratio7.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.18%
Min EPS beat(2)-10.75%
Max EPS beat(2)85.11%
EPS beat(4)3
Avg EPS beat(4)23.84%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)7
Avg EPS beat(8)23.11%
EPS beat(12)11
Avg EPS beat(12)23.04%
EPS beat(16)14
Avg EPS beat(16)21.73%
Revenue beat(2)2
Avg Revenue beat(2)1.53%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.95%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.18%
Revenue beat(12)5
Avg Revenue beat(12)-0.58%
Revenue beat(16)7
Avg Revenue beat(16)-0.94%
PT rev (1m)0.64%
PT rev (3m)11.39%
EPS NQ rev (1m)1.32%
EPS NQ rev (3m)1.05%
EPS NY rev (1m)-0.5%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.34%
Valuation
Industry RankSector Rank
PE 67.54
Fwd PE 50.6
P/S 10.43
P/FCF 63.88
P/OCF 60.61
P/B 10.63
P/tB 40.08
EV/EBITDA 82.73
EPS(TTM)1.59
EY1.48%
EPS(NY)2.12
Fwd EY1.98%
FCF(TTM)1.68
FCFY1.57%
OCF(TTM)1.77
OCFY1.65%
SpS10.3
BVpS10.1
TBVpS2.68
PEG (NY)10.79
PEG (5Y)1.41
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROCE 8.03%
ROIC 7.28%
ROICexc 8.76%
ROICexgc 36.88%
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
FCFM 16.32%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.33
Cap/Depr 26.88%
Cap/Sales 0.88%
Interest Coverage 250
Cash Conversion 138.51%
Profit Quality 336.48%
Current Ratio 1.11
Quick Ratio 1.04
Altman-Z 14.11
F-Score5
WACC11.05%
ROIC/WACC0.66
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%
EBIT growth 1Y17.78%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year173.69%
EBIT Next 3Y69.32%
EBIT Next 5Y56.79%
FCF growth 1Y94.78%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y44.43%
OCF growth 3Y24.6%
OCF growth 5Y39.06%